According to the analyses between the MS and control groups, there was a statistically significant increase (p < 0.001) in the frequency of the TAS2R16 rs860170 CC genotype and a statistically significant difference (p = 0.041) in the frequency of the TAS2R16 rs860170 TT genotype. Here, TAS2R16 is linked to myeloid sarcoma.